Related Experiment Video
Updated: Jul 14, 2026
06:28
Single Step Isolation of Extracellular Vesicles from Large-Volume Samples with a Bifurcated A4F Microfluidic Device
Published on: February 2, 2024
Miniaturized asymmetrical flow field-flow fractionation: application to biological vesicles
Sunok Oh1, Dukjin Kang, Sung-Min Ahn
1Department of Chemistry, Yonsei University, Seoul, Korea.
Journal of Separation Science
|June 15, 2007
Summary
Miniaturized asymmetrical flow field-flow fractionation (AFlFFF) enables rapid separation of proteins and exosomes. This technique achieves efficient fractionation of exosomes by size, valuable for proteomic and immunotherapeutic research.
Area of Science:
- Biochemistry
- Nanotechnology
- Cell Biology
Background:
- Asymmetrical flow field-flow fractionation (AFlFFF) is a technique for separating macromolecules and particles.
- Miniaturization of analytical instruments offers advantages in speed and sample consumption.
Purpose of the Study:
- To develop and evaluate a miniaturized AFlFFF (mAFlFFF) channel for enhanced separation efficiency.
- To assess the mAFlFFF channel's capability in fractionating exosomes for proteomic and immunotherapeutic applications.
Main Methods:
- AFlFFF was performed using a miniaturized channel with reduced dimensions.
- The performance was evaluated using standard proteins and polystyrene latex spheres (nanometer to micrometer size).
- Exosomes were harvested from an immortalized human mesenchymal stem cell line and separated using mAFlFFF.
Main Results:
- The mAFlFFF channel demonstrated rapid separation of proteins and particulate materials within minutes.
- Efficient separation with minimal loss of resolution was achieved for a wide range of particle sizes.
- Successful fractionation of exosome vesicles based on size was observed.
Conclusions:
- Miniaturized AFlFFF provides a fast and high-resolution method for separating biological macromolecules and nanoparticles.
- The mAFlFFF channel shows significant potential for size-based exosome fractionation, aiding proteomic studies and advancing immunotherapeutic research.
